Skip to main content

Advertisement

SpringerLink
Log in

Chronic Sustained Hypoxia Leads to Brainstem Tauopathy and Declines the Power of Rhythms in the Ventrolateral Medulla: Shedding Light on a Possible Mechanism

  • Published:
Molecular Neurobiology Aims and scope Submit manuscript

Abstract

Hypoxia, especially the chronic type, leads to disruptive results in the brain that may contribute to the pathogenesis of some neurodegenerative diseases such as Alzheimer’s disease (AD). The ventrolateral medulla (VLM) contains clusters of interneurons, such as the pre-Bötzinger complex (preBötC), that generate the main respiratory rhythm drive. We hypothesized that exposing animals to chronic sustained hypoxia (CSH) might develop tauopathy in the brainstem, consequently changing the rhythmic manifestations of respiratory neurons. In this study, old (20–22 months) and young (2–3 months) male rats were subjected to CSH (10 ± 0.5% O2) for ten consecutive days. Western blotting and immunofluorescence (IF) staining were used to evaluate phosphorylated tau. Mitochondrial membrane potential (MMP or ∆ψm) and reactive oxygen species (ROS) production were measured to assess mitochondrial function. In vivo diaphragm’s electromyography (dEMG) and local field potential (LFP) recordings from preBötC were employed to assess the respiratory factors and rhythmic representation of preBötC, respectively. Findings showed that ROS production increased significantly in hypoxic groups, associated with a significant decline in ∆ψm. In addition, tau phosphorylation elevated in the brainstem of hypoxic groups. On the other hand, the power of rhythms declined significantly in the preBötC of hypoxic rats, parallel with changes in the respiratory rate, total respiration time, and expiration time. Moreover, there was a positive and statistically significant correlation between LFP rhythm’s power and inspiration time. Our data showed that besides CSH, aging also contributed to mitochondrial dysfunction, tau hyperphosphorylation, LFP rhythms’ power decline, and changes in respiratory factors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

Data Availability

The datasets used and analyzed during the current study are available from the corresponding author upon reasonable request.

Abbreviations

AD:

Alzheimer’s disease

preBötC:

The pre-Bötzinger complex

VLM:

Ventrolateral medulla

CSH:

Chronic sustained hypoxia

ROS:

Reactive oxygen species

dEMG:

Diaphragm muscle electromyography

LFP:

Local field potential

MMP:

Mitochondrial membrane potential

MAP:

Microtubule-associated protein

GSK3β:

Glycogen synthase kinase-3β

CDK5:

Cyclin-dependent kinase 5

NFTs:

Neurofibrillary tangles

PHF:

Paired helical filaments

CIH:

Chronic intermittent hypoxia

OSAS:

Obstructive sleep apnea syndrome

PP2A:

Protein phosphatase A2

VRG:

Ventral respiratory group

rVRG:

Ventral respiratory group, rostral part

EEG:

Electroencephalography

4V:

Fourth ventricle

Sp5:

Spinal trigeminal tract

Sp5I:

Interpolar nucleus of spinal trigeminal nucleus

AmbC:

Compact part of the ambiguous nucleus

12N:

Hypoglossal nucleus

NTS:

Nucleus tractus solitarius

IOD:

Inferior olive dorsal nucleus

IOPr:

Inferior olive principal nucleus

IOM:

Inferior olive medial nucleus

py:

Pyramidal tract

IF:

Immunofluorescence

mtDNA:

Mitochondrial DNA

PHFD:

Post hypoxic frequency decline

VAH:

Ventilatory acclimatization to hypoxia

References

  1. Thomas LW, Ashcroft M (2019) Exploring the molecular interface between hypoxia-inducible factor signalling and mitochondria. Cell Mol Life Sci 76(9):1759–1777

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Abe H, Semba H, Takeda N (2017) The roles of hypoxia signaling in the pathogenesis of cardiovascular diseases. J Atheroscler Thromb 24(9):884–894

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Brent MB (2022) A review of the skeletal effects of exposure to high altitude and potential mechanisms for hypobaric hypoxia-induced bone loss. Bone 154:116258

    Article  CAS  PubMed  Google Scholar 

  4. Asmaro D, Mayall J, Ferguson S (2013) Cognition at altitude: impairment in executive and memory processes under hypoxic conditions. Aviat Space Environ Med 84(11):1159–1165

    Article  PubMed  Google Scholar 

  5. Kent BD, Mitchell PD, McNicholas WT (2011) Hypoxemia in patients with COPD: cause, effects, and disease progression. Int J Chron Obstruct Pulmon Dis 6:199

    PubMed  PubMed Central  Google Scholar 

  6. Small DH, Cappai R (2006) Alois Alzheimer and Alzheimer’s disease: a centennial perspective. J Neurochem 99(3):708–710

    Article  CAS  PubMed  Google Scholar 

  7. Giacobini E, Gold G (2013) Alzheimer disease therapy—moving from amyloid-β to tau. Nat Rev Neurol 9(12):677–686

    Article  CAS  PubMed  Google Scholar 

  8. Pîrşcoveanu DFV, Pirici I, Tudorică V, Bălşeanu TA, Albu VC, Bondari S, Bumbea AM, Pîrşcoveanu M (2017) Tau protein in neurodegenerative diseases - a review. Rom J Morphol Embryol 58(4):1141–1150

    PubMed  Google Scholar 

  9. Wagner U et al (1996) Cellular phosphorylation of tau by GSK-3 beta influences tau binding to microtubules and microtubule organisation. J Cell Sci 109(Pt 6):1537–1543

    Article  CAS  PubMed  Google Scholar 

  10. Kimura T, Ishiguro K, Hisanaga S (2014) Physiological and pathological phosphorylation of tau by Cdk5. Front Mol Neurosci 7:65

    Article  PubMed  PubMed Central  Google Scholar 

  11. Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17(1):5–21

    Article  PubMed  Google Scholar 

  12. Chen K (2020) Phosphorylation of the tau protein in neurodegenerative disease. Biomed J Sci Tech Res 26(4)

  13. Mietelska-Porowska A et al (2014) Tau protein modifications and interactions: their role in function and dysfunction. Int J Mol Sci 15(3):4671–4713

    Article  PubMed  PubMed Central  Google Scholar 

  14. Duquette A et al (2021) Similarities and differences in the pattern of tau hyperphosphorylation in physiological and pathological conditions: impacts on the elaboration of therapies to prevent tau pathology. Front Neurol 11:607680

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kazim SF et al (2022) Chronic intermittent hypoxia enhances pathological tau seeding, propagation, and accumulation and exacerbates Alzheimer-like memory and synaptic plasticity deficits and molecular signatures. Biol Psychiatry 91(4):346–358

    Article  CAS  PubMed  Google Scholar 

  16. Raz L et al (2019) Hypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunction. Neurobiol Dis 126:124–136

    Article  CAS  PubMed  Google Scholar 

  17. Qiu L et al (2016) Chronic cerebral hypoperfusion enhances tau hyperphosphorylation and reduces autophagy in Alzheimer’s disease mice. Sci Rep 6(1):23964

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Bu X-L et al (2015) Serum amyloid-beta levels are increased in patients with obstructive sleep apnea syndrome. Sci Rep 5(1):13917

    Article  PubMed  PubMed Central  Google Scholar 

  19. Liu H et al (2016) Chronic hypoxia facilitates Alzheimer’s disease through demethylation of γ-secretase by downregulating DNA methyltransferase 3b. Alzheimers Dement 12(2):130–143

    Article  PubMed  Google Scholar 

  20. Biswal S et al (2016) Global hypoxia induced impairment in learning and spatial memory is associated with precocious hippocampal aging. Neurobiol Learn Mem 133:157–170

    Article  CAS  PubMed  Google Scholar 

  21. Chen G-J et al (2003) Transient hypoxia causes Alzheimer-type molecular and biochemical abnormalities in cortical neurons: potential strategies for neuroprotection. J Alzheimers Dis 5:209–228

    Article  PubMed  Google Scholar 

  22. Jain K et al (2015) Hypobaric hypoxia imbalances mitochondrial dynamics in rat brain hippocampus. Neurol Res Int 2015:742059

    Article  PubMed  PubMed Central  Google Scholar 

  23. Onyango IG, Dennis J, Khan SM (2016) Aging Dis 7(2):201–214

    Article  PubMed  PubMed Central  Google Scholar 

  24. Wu Y, Chen M, Jiang J (2019) Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion 49:35–45

    Article  CAS  PubMed  Google Scholar 

  25. Rey F et al (2022) Mitochondrial dysfunctions in neurodegenerative diseases: role in disease pathogenesis, strategies for analysis and therapeutic prospects. Neural Regen Res 17(4):754

    Article  CAS  PubMed  Google Scholar 

  26. Sena LA, Chandel NS (2012) Physiological roles of mitochondrial reactive oxygen species. Mol Cell 48(2):158–167

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Zhang B et al (2022) Role of mitochondrial reactive oxygen species in homeostasis regulation. Redox Rep 27(1):45–52

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Melov S et al (2007) Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS ONE 2(6):e536

    Article  PubMed  PubMed Central  Google Scholar 

  29. Gaig C, Iranzo A (2012) Sleep-disordered breathing in neurodegenerative diseases. Curr Neurol Neurosci Rep 12(2):205–217

    Article  PubMed  Google Scholar 

  30. Jorge C et al (2020) Obstructive sleep apnoea and cognitive decline in mild-to-moderate Alzheimer’s disease. Eur Respir J 56(5):2000523

    Article  PubMed  Google Scholar 

  31. Affoo RH et al (2013) Swallowing dysfunction and autonomic nervous system dysfunction in Alzheimer’s disease: a scoping review of the evidence. J Am Geriatr Soc 61(12):2203–2213

    Article  PubMed  Google Scholar 

  32. Dutschmann M et al (2010) Upper airway dysfunction of tau-P301L mice correlates with tauopathy in midbrain and ponto-medullary brainstem nuclei. J Neurosci 30(5):1810–1821

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Ebel DL, Torkilsen CG, Ostrowski TD (2017) Blunted respiratory responses in the streptozotocin-induced Alzheimer’s disease rat model. J Alzheimers Dis 56:1197–1211

    Article  CAS  PubMed  Google Scholar 

  34. Trease AJ et al (2022) Hyperphosphorylated human tau accumulates at the synapse, localizing on synaptic mitochondrial outer membranes and disrupting respiration in a mouse model of tauopathy. Front Mol Neurosci 15:852368

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Smith JC et al (2007) Spatial and functional architecture of the mammalian brain stem respiratory network: a hierarchy of three oscillatory mechanisms. J Neurophysiol 98(6):3370–3387

    Article  CAS  PubMed  Google Scholar 

  36. Smith JC et al (1991) Pre-Bötzinger complex: a brainstem region that may generate respiratory rhythm in mammals. Science 254(5032):726–729

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Jiang C, Lipski J (1990) Extensive monosynaptic inhibition of ventral respiratory group neurons by augmenting neurons in the Bötzinger complex in the cat. Exp Brain Res 81(3):639–648

    Article  CAS  PubMed  Google Scholar 

  38. Garcia AJ et al (2016) Chronic intermittent hypoxia alters local respiratory circuit function at the level of the preBötzinger complex. Front Neurosci 10

  39. Kiatchoosakun P et al (2002) Effects of hypoxia on respiratory neural output and lower esophageal sphincter pressure in piglets. Pediatr Res 52(1):50–55

    Article  PubMed  Google Scholar 

  40. England SJ et al (1995) Activity of respiratory neurons during hypoxia in the chemodenervated cat. J Appl Physiol 78(3):856–861

    Article  CAS  PubMed  Google Scholar 

  41. Richter DW, Müller M (2009) Neural respiratory control during acute hypoxia. In: Binder MD, Hirokawa N, Windhorst U (eds) Encyclopedia of neuroscience. Springer, Berlin Heidelberg, Berlin, pp 2601–2606

    Chapter  Google Scholar 

  42. Alonso AC et al (1994) Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer’s disease. Proc Natl Acad Sci 91(12):5562–5566

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Nishioka C et al (2022) Axonal transport impairment and its relationship with diffusion tensor imaging metrics of a murine model of p301L tau induced tauopathy. Neuroscience 498:144–154

    Article  CAS  PubMed  Google Scholar 

  44. Menkes-Caspi N et al (2015) Pathological tau disrupts ongoing network activity. Neuron 85(5):959–966

    Article  CAS  PubMed  Google Scholar 

  45. Maleysson V et al (2019) Relevance of electroencephalogram assessment in amyloid and tau pathology in rat. Behav Brain Res 359:127–134

    Article  CAS  PubMed  Google Scholar 

  46. Xu Y, Fan Q (2022) Relationship between chronic hypoxia and seizure susceptibility. CNS Neurosci Ther 28(11):1689–1705

    Article  PubMed  PubMed Central  Google Scholar 

  47. Pamenter ME, Powell FL (2016) Time domains of the hypoxic ventilatory response and their molecular basis. Compr Physiol 6(3):1345–1385

    Article  PubMed  PubMed Central  Google Scholar 

  48. Bayer C et al (2011) Acute versus chronic hypoxia: why a simplified classification is simply not enough. Int J Radiat Oncol Biol Phys 80(4):965–968

    Article  PubMed  Google Scholar 

  49. Hossienzadeh F et al (2013) Effect of ghrelin on brain edema induced by acute and chronic systemic hypoxia. Neurosci Lett 534:47–51

    Article  CAS  PubMed  Google Scholar 

  50. Subramanian HH, Holstege G (2013) Stimulation of the midbrain periaqueductal gray modulates preinspiratory neurons in the ventrolateral medulla in the rat in vivo. J Comp Neurol 521(13):3083–3098

    Article  PubMed  PubMed Central  Google Scholar 

  51. Delorme A, Makeig S (2004) EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods 134(1):9–21

    Article  PubMed  Google Scholar 

  52. Hayes MH (1996) Statistical digital signal processing and modeling. Wiley

    Google Scholar 

  53. Soltani Zangbar H et al (2020) A potential entanglement between the spinal cord and hippocampus: theta rhythm correlates with neurogenesis deficiency following spinal cord injury in male rats. J Neurosci Res 98(12):2451–2467

    Article  CAS  PubMed  Google Scholar 

  54. Liao P-C et al (2020) Chapter 1 - isolation of mitochondria from cells and tissues. In: Pon LA, Schon EA (eds) Methods in cell biology. Academic Press, pp 3–31

    Google Scholar 

  55. Hosseini L, Vafaee MS, Badalzadeh R (2020) Melatonin and nicotinamide mononucleotide attenuate myocardial ischemia/reperfusion injury via modulation of mitochondrial function and hemodynamic parameters in aged rats. J Cardiovasc Pharmacol Ther 25(3):240–250

    Article  CAS  PubMed  Google Scholar 

  56. Liu F et al (2018) Mitochondria in ischemic stroke: new insight and implications. Aging Dis 9(5):924–937

    Article  PubMed  PubMed Central  Google Scholar 

  57. Wang W et al (2020) Mitochondria dysfunction in the pathogenesis of Alzheimer’s disease: recent advances. Mol Neurodegener 15:1–22

    Article  Google Scholar 

  58. Turrens JF (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552(Pt 2):335–344

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Korshunov SS, Skulachev VP, Starkov AA (1997) High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 416(1):15–18

    Article  CAS  PubMed  Google Scholar 

  60. Sugrue MM, Tatton WG (2001) Mitochondrial membrane potential in aging cells. Biol Signals Recept 10(3–4):176–188

    Article  CAS  PubMed  Google Scholar 

  61. Madamanchi NR, Runge MS (2007) Mitochondrial dysfunction in atherosclerosis. Circ Res 100(4):460–473

    Article  CAS  PubMed  Google Scholar 

  62. Ohashi S et al (2006) Protective roles of redox-active protein thioredoxin-1 for severe acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 290(4):G772-81

    Article  CAS  PubMed  Google Scholar 

  63. Lobo V et al (2010) Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev 4(8):118–126

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Reddy PH (2009) Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer’s disease. Exp Neurol 218(2):286–292

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Deshpande A et al (2006) Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26(22):6011–6018

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Cabezas-Opazo FA et al (2015) Mitochondrial dysfunction contributes to the pathogenesis of Alzheimer’s disease. Oxid Med Cell Longev 2015:509654

    Article  PubMed  PubMed Central  Google Scholar 

  67. Aon MA, Cortassa S, O’Rourke B (2010) Redox-optimized ROS balance: a unifying hypothesis. Biochim Biophys Acta 1797(6–7):865–877

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Fan Q et al (2013) Aging might augment reactive oxygen species (ROS) formation and affect reactive nitrogen species (RNS) level after myocardial ischemia/reperfusion in both humans and rats. Age (Dordr) 35(4):1017–1026

    Article  CAS  PubMed  Google Scholar 

  69. Calabrese V et al (2004) Increased expression of heat shock proteins in rat brain during aging: relationship with mitochondrial function and glutathione redox state. Mech Ageing Dev 125(4):325–335

    Article  CAS  PubMed  Google Scholar 

  70. Mecocci P et al (1993) Oxidative damage to mitochondrial DNA shows marked age-dependent increases in human brain. Ann Neurol 34(4):609–616

    Article  CAS  PubMed  Google Scholar 

  71. Alquezar C, Arya S, Kao AW (2021) Tau post-translational modifications: dynamic transformers of tau function, degradation, and aggregation. Front Neurol 11:595532

    Article  PubMed  PubMed Central  Google Scholar 

  72. Zhang C-E et al (2014) Hypoxia-induced tau phosphorylation and memory deficit in rats. Neurodegener Dis 14:107–116

    Article  CAS  PubMed  Google Scholar 

  73. Gong C-X et al (1995) Phosphatase activity toward abnormally phosphorylated τ: decrease in Alzheimer disease brain. J Neurochem 65(2):732–738

    Article  CAS  PubMed  Google Scholar 

  74. Guha S, Johnson GV, Nehrke K (2020) The crosstalk between pathological tau phosphorylation and mitochondrial dysfunction as a key to understanding and treating Alzheimer’s disease. Mol Neurobiol 57:5103–5120

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Sies H, Jones DP (2020) Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol 21(7):363–383

    Article  CAS  PubMed  Google Scholar 

  76. Jones DP, Sies H (2015) The redox code. Antioxid Redox Signal 23(9):734–746

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Mailloux RJ, Jin X, Willmore WG (2014) Redox regulation of mitochondrial function with emphasis on cysteine oxidation reactions. Redox Biol 2:123–139

    Article  CAS  PubMed  Google Scholar 

  78. Martínez-Reyes I, Cuezva JM (2014) The H(+)-ATP synthase: a gate to ROS-mediated cell death or cell survival. Biochem Biophys Acta 1837(7):1099–1112

    PubMed  Google Scholar 

  79. Rhee SG et al (2000) Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE 2000(53):pe1

    Article  CAS  PubMed  Google Scholar 

  80. Tonks NK (2005) Redox redux: revisiting PTPs and the control of cell signaling. Cell 121(5):667–670

    Article  CAS  PubMed  Google Scholar 

  81. Muyllaert D et al (2008) Glycogen synthase kinase-3β, or a link between amyloid and tau pathology? Genes Brain Behav 7(s1):57–66

    Article  CAS  PubMed  Google Scholar 

  82. Toral-Rios D et al (2020) GSK3β and tau protein in Alzheimer’s disease and epilepsy. Front Cell Neurosci 14:19

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  83. Liu K et al (2016) Glycation alter the process of tau phosphorylation to change tau isoforms aggregation property. Biochimica et Biophysica Acta (BBA) - Mol Basis Dis 1862(2):192–201

    Article  CAS  Google Scholar 

  84. Sui D, Liu M, Kuo M-H (2015) In vitro aggregation assays using hyperphosphorylated tau protein. JoVE 95:e51537

    Google Scholar 

  85. Hemmings BA, Cohen P (1983) [36] Glycogen synthase kinase-3 from rabbit skeletal muscle. Methods in enzymology. Academic Press, pp 337–345

    Google Scholar 

  86. Harik SI et al (1995) Brain glucose metabolism in hypobaric hypoxia. J Appl Physiol 79(1):136–140

    Article  CAS  PubMed  Google Scholar 

  87. Wang SH et al (2009) Cadmium toxicity toward autophagy through ROS-activated GSK-3beta in mesangial cells. Toxicol Sci 108(1):124–131

    Article  CAS  PubMed  Google Scholar 

  88. Pizarro JG et al (2008) Neuroprotective effects of SB-415286 on hydrogen peroxide-induced cell death in B65 rat neuroblastoma cells and neurons. Int J Dev Neurosci 26(3–4):269–276

    Article  CAS  PubMed  Google Scholar 

  89. Chauhan NB, Siegel GJ, Feinstein DL (2005) Propentofylline attenuates tau hyperphosphorylation in Alzheimer’s Swedish mutant model Tg2576. Neuropharmacology 48(1):93–104

    Article  CAS  PubMed  Google Scholar 

  90. Strocchi P, Pession A, Dozza B (2003) Up-regulation of cDK5/p35 by oxidative stress in human neuroblastoma IMR-32 cells. J Cell Biochem 88(4):758–765

    Article  CAS  PubMed  Google Scholar 

  91. Shea TB et al (2004) Cyclin-dependent kinase 5 increases perikaryal neurofilament phosphorylation and inhibits neurofilament axonal transport in response to oxidative stress. J Neurosci Res 76(6):795–800

    Article  CAS  PubMed  Google Scholar 

  92. Smith PD, O’Hare MJ, Park DS (2004) Emerging pathogenic role for cyclin dependent kinases in neurodegeneration. Cell Cycle 3(3):289–291

    Article  CAS  PubMed  Google Scholar 

  93. Patrick GN et al (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402(6762):615–622

    Article  CAS  PubMed  Google Scholar 

  94. Gong C-X et al (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61(3):921–927

    Article  CAS  PubMed  Google Scholar 

  95. Liu R et al (2008) Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology. J Cell Mol Med 12(1):241–257

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Orellana AMM et al (2015) Age-related neuroinflammation and changes in AKT-GSK-3β and WNT/β-catenin signaling in rat hippocampus. Aging 7(12):1094–1111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. Lee K-Y et al (1999) Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain. Neurosci Res 34(1):21–29

    Article  CAS  PubMed  Google Scholar 

  98. Kelleher I et al (2007) Kinase activities increase during the development of tauopathy in htau mice. J Neurochem 103(6):2256–2267

    Article  CAS  PubMed  Google Scholar 

  99. Leroy A et al (2010) Spectroscopic studies of GSK3β phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E. J Biol Chem 285(43):33435–33444

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Paudel HK et al (1993) Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer’s paired helical filaments. J Biol Chem 268(31):23512–23518

    Article  CAS  PubMed  Google Scholar 

  101. Uematsu M et al (2018) Brainstem tau pathology in Alzheimer’s disease is characterized by increase of three repeat tau and independent of amyloid β. Acta Neuropathol Commun 6(1):1

    Article  PubMed  PubMed Central  Google Scholar 

  102. Wai MS et al (2009) Co-localization of hyperphosphorylated tau and caspases in the brainstem of Alzheimer’s disease patients. Biogerontology 10(4):457–469

    Article  CAS  PubMed  Google Scholar 

  103. Hirano A, Zimmerman HM (1962) Alzheimer’s neurofibrillary changes. A topographic study. Arch Neurol 7:227–242

    Article  CAS  PubMed  Google Scholar 

  104. Ishii T (1966) Distribution of Alzheimer’s neurofibrillary changes in the brain stem and hypothalamus of senile dementia. Acta Neuropathol 6(2):181–187

    Article  CAS  PubMed  Google Scholar 

  105. Zhu K et al (2019) Primary age-related tauopathy in human subcortical nuclei. Front Neurosci 13:529

    Article  PubMed  PubMed Central  Google Scholar 

  106. Liu SJ et al (2003) Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory. J Neurochem 87(6):1333–1344

    Article  CAS  PubMed  Google Scholar 

  107. Buée L et al (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res Rev 33(1):95–130

    Article  PubMed  Google Scholar 

  108. Zhang Y et al (2022) Tauopathies: new perspectives and challenges. Mol Neurodegener 17(1):28

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Hoover BR et al (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68(6):1067–1081

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. Yoshiyama Y et al (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53(3):337–351

    Article  CAS  PubMed  Google Scholar 

  111. Wu M et al (2021) The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases. Transl Neurodegen 10:1–11

    Article  Google Scholar 

  112. Holton CM et al (2020) Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration. Alzheimers Res Ther 12(1):84

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  113. Scarpa JR et al (2021) NREM delta power and AD-relevant tauopathy are associated with shared cortical gene networks. Sci Rep 11(1):7797

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  114. Holth JK et al (2017) Altered sleep and EEG power in the P301S tau transgenic mouse model. Ann Clin Transl Neurol 4:180–190. https://doi.org/10.1002/acn3.390

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Ahnaou A et al (2020) Functional alterations in the olfactory neuronal circuit occur before hippocampal plasticity deficits in the P301S mouse model of tauopathy: implications for early diagnosis and translational research in Alzheimer’s disease. Int J Mol Sci 21(15):5431

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Buzsáki G, Anastassiou CA, Koch C (2012) The origin of extracellular fields and currents—EEG, ECoG, LFP and spikes. Nat Rev Neurosci 13(6):407–420

    Article  PubMed  PubMed Central  Google Scholar 

  117. Polich J (1997) EEG and ERP assessment of normal aging. Electroencephal Clin Neurophysiol/Evoked Potent Sect 104(3):244–256

    Article  CAS  Google Scholar 

  118. Kreuzer M et al (2020) Spectral and entropic features are altered by age in the electroencephalogram in patients under sevoflurane anesthesia. Anesthesiology 132(5):1003–1016

    Article  PubMed  Google Scholar 

  119. Babiloni C et al (2006) Sources of cortical rhythms in adults during physiological aging: a multicentric EEG study. Hum Brain Mapp 27(2):162–172

    Article  PubMed  Google Scholar 

  120. Jyoti A et al (2015) Progressive age-related changes in sleep and EEG profiles in the PLB1Triple mouse model of Alzheimer’s disease. Neurobiol Aging 36(10):2768–2784

    Article  PubMed  Google Scholar 

  121. Agnati LF et al (1990) Cellular and synaptic alterations in the aging brain. Aging Clin Exp Res 2(1):5–25

    Article  CAS  Google Scholar 

  122. Mostany R et al (2013) Altered synaptic dynamics during normal brain aging. J Neurosci 33(9):4094

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Ishii R et al (2017) Healthy and pathological brain aging: from the perspective of oscillations, functional connectivity, and signal complexity. Neuropsychobiology 75(4):151–161

    Article  PubMed  Google Scholar 

  124. Monteau R, Hilaire G (1991) Spinal respiratory motoneurons. Prog Neurobiol 37(2):83–144

    Article  CAS  PubMed  Google Scholar 

  125. Walsh MP, Marshall JM (2006) The early effects of chronic hypoxia on the cardiovascular system in the rat: role of nitric oxide. J Physiol 575(1):263–275

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. Perim RR, Bonagamba LGH, Machado BH (2015) Cardiovascular and respiratory outcome of preconditioned rats submitted to chronic intermittent hypoxia. Exp Physiol 100(9):1008–1017

    Article  PubMed  Google Scholar 

  127. Kinkead R, Mitchell GS (1999) Time-dependent hypoxic ventilatory responses in rats: effects of ketanserin and 5-carboxamidotryptamine. Am J Physiol-Regul Integr Comp Physiol 277(3):R658–R666

    Article  CAS  Google Scholar 

  128. Aaron EA, Powell FL (1993) Effect of chronic hypoxia on hypoxic ventilatory response in awake rats. J Appl Physiol 74(4):1635–1640

    Article  CAS  PubMed  Google Scholar 

  129. Dempsey JA et al (2014) Role of chemoreception in cardiorespiratory acclimatization to, and deacclimatization from, hypoxia. J Appl Physiol (1985) 116(7):858–66

    Article  PubMed  Google Scholar 

  130. Forster HV et al (1976) Ventilatory control in peripheral chemoreceptor-denervated ponies during chronic hypoxemia. J Appl Physiol 41(6):878–885

    Article  CAS  PubMed  Google Scholar 

  131. Forster HV et al (1974) Evidence of altered regulation of ventilation during exposure to hypoxia. Respir Physiol 20(3):379–392

    Article  CAS  PubMed  Google Scholar 

  132. Wilkinson KA et al (2010) Chronic hypoxia increases the gain of the hypoxic ventilatory response by a mechanism in the central nervous system. J Appl Physiol (1985) 109(2):424–30

    Article  PubMed  Google Scholar 

  133. Attems J et al (2005) Cause of death in demented and non-demented elderly inpatients; an autopsy study of 308 cases. J Alzheimers Dis 8(1):57–62

    Article  PubMed  Google Scholar 

  134. Katz DM et al (2009) Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth. Respir Physiol Neurobiol 168(1–2):101–108

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  135. Menuet C et al (2012) Isoflurane anesthesia precipitates tauopathy and upper airways dysfunction in pre-symptomatic Tau.P301L mice: possible implication for neurodegenerative diseases. Neurobiol Dis 46(1):234–43

    Article  CAS  PubMed  Google Scholar 

  136. Menuet C et al (2011) Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer’s disease. Respir Physiol Neurobiol 178(2):290–303

    Article  CAS  PubMed  Google Scholar 

  137. Terwel D et al (2005) Changed conformation of mutant tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of tau-4R/2N transgenic mice. J Biol Chem 280(5):3963–3973

    Article  CAS  PubMed  Google Scholar 

  138. Wu M, Haxhiu MA, Johnson SM (2005) Hypercapnic and hypoxic responses require intact neural transmission from the pre-Bötzinger complex. Respir Physiol Neurobiol 146(1):33–46

    Article  PubMed  Google Scholar 

  139. Baux G, Simonneau M, Tauc L (1981) Action of colchicine on membrane currents and synaptic transmission in Aplysia ganglion cells. J Neurobiol 12(1):75–85

    Article  CAS  PubMed  Google Scholar 

  140. Donoso AL, Fernandez HL (1973) Effect of colchicine on long lasting synaptic modifications induced by hyperactivity. Experientia 29(9):1089–1090

    Article  CAS  PubMed  Google Scholar 

  141. Sharma G, Goodwin J (2006) Effect of aging on respiratory system physiology and immunology. Clin Interv Aging 1(3):253–260

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  142. Krumpe PE et al (1985) The aging respiratory system. Clin Geriatr Med 1(1):143–175

    Article  CAS  PubMed  Google Scholar 

  143. Sprung J, Gajic O, Warner DO (2006) Review article: age related alterations in respiratory function - anesthetic considerations. Can J Anaesth 53(12):1244–1257

    Article  PubMed  Google Scholar 

  144. Logothetis NK et al (2001) Neurophysiological investigation of the basis of the fMRI signal. Nature 412(6843):150–157

    Article  CAS  PubMed  Google Scholar 

  145. McCormick DA et al (2003) Persistent cortical activity: mechanisms of generation and effects on neuronal excitability. Cereb Cortex 13(11):1219–1231

    Article  PubMed  Google Scholar 

  146. Penttonen M et al (1998) Gamma frequency oscillation in the hippocampus of the rat: intracellular analysis in vivo. Eur J Neurosci 10(2):718–728

    Article  CAS  PubMed  Google Scholar 

  147. Anderson J et al (2000) Stimulus dependence of two-state fluctuations of membrane potential in cat visual cortex. Nat Neurosci 3(6):617–621

    Article  CAS  PubMed  Google Scholar 

  148. Logothetis NK, Wandell BA (2004) Interpreting the BOLD signal. Annu Rev Physiol 66:735–769

    Article  CAS  PubMed  Google Scholar 

  149. Henrie JA, Shapley R (2005) LFP power spectra in V1 cortex: the graded effect of stimulus contrast. J Neurophysiol 94(1):479–490

    Article  PubMed  Google Scholar 

  150. Buzsáki G, Wang XJ (2012) Mechanisms of gamma oscillations. Annu Rev Neurosci 35:203–225

    Article  PubMed  PubMed Central  Google Scholar 

  151. Lytton WW, Sejnowski TJ (1991) Simulations of cortical pyramidal neurons synchronized by inhibitory interneurons. J Neurophysiol 66(3):1059–1079

    Article  CAS  PubMed  Google Scholar 

  152. Gray CM et al (1989) Oscillatory responses in cat visual cortex exhibit inter-columnar synchronization which reflects global stimulus properties. Nature 338(6213):334–337

    Article  CAS  PubMed  Google Scholar 

  153. Brown P (2000) Cortical drives to human muscle: the Piper and related rhythms. Prog Neurobiol 60(1):97–108

    Article  CAS  PubMed  Google Scholar 

  154. Engelhard B, Vaadia E (2014) Spatial computation with gamma oscillations. Front Syst Neurosci 8

Download references

Acknowledgements

The authors would like to express their gratitude to Pouran Karimi for her assistance in molecular analysis. Our data were derived from the thesis of Jamal Khalilpour for a Ph.D. degree in physiology.

Funding

This work was supported by grants (No. 65698) from Drug Applied Research Center, Tabriz University of Medical Science.

Author information

Authors and Affiliations

  1. Drug Applied Research Center, Tabriz University of Medical Sciences, Golgasht Street, Tabriz, East Azerbaijan, Iran

    Jamal Khalilpour, Mohammad Reza Alipour, Zohre Zavari & Parviz Shahabi

  2. Department of Physiology, Faculty of Medicine, Urmia University of Medical Sciences, Urmia, Iran

    Firouz Qaderi Pakdel

  3. Department of Neuroscience, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Golgasht Street, Tabriz, East Azerbaijan, Iran

    Hamid Soltani Zangbar

Authors
  1. Jamal Khalilpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hamid Soltani Zangbar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammad Reza Alipour
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Firouz Qaderi Pakdel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zohre Zavari
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Parviz Shahabi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JK and PS conceived the study and designed the experiments. JK wrote the manuscript. JK, PS, and HSZ performed the experiments with the help of ZZ. JK, PS, HSZ, MRA, and FQP interpreted data and contributed to the discussion. All authors reviewed and concurred with the final manuscript. PS takes responsibility for the integrity of the data and the accuracy of the data analysis.

Corresponding authors

Correspondence to Hamid Soltani Zangbar or Parviz Shahabi.

Ethics declarations

Ethics Approval

All procedures and handling techniques were approved by the Ethical Committee for Animal Research of Tabriz University of Medical Sciences (IR.TBZMED.VCR.REC.1399.404), and surgical procedures were conducted under aseptic conditions.

Consent to Participate

Not applicable.

Consent for Publication

Not applicable.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khalilpour, J., Zangbar, H.S., Alipour, M.R. et al. Chronic Sustained Hypoxia Leads to Brainstem Tauopathy and Declines the Power of Rhythms in the Ventrolateral Medulla: Shedding Light on a Possible Mechanism. Mol Neurobiol 61, 3121–3143 (2024). https://doi.org/10.1007/s12035-023-03763-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12035-023-03763-4

Keywords

Search

Navigation